跳至主要内容
临床试验/ACTRN12610000293066
ACTRN12610000293066已完成3 期

The LoDoCo Trial: The effect of low dose colchicine on the natural history of patients with stable coronary artery disease

Mark Nidorf0 个研究点目标入组 525 人开始时间: 2010年4月13日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
525

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
35 Years 至 85 Years(—)
性别
All

入选标准

  • Angiographic proof of coronary disease
  • Clinically stable for >6months
  • Coronary Artery Bypass Grafting [CABG] more than 10 years ago or CABG at any time if the patient had subesquently had recurrent angina and angiographic evidence of blocked grafts or progressive native coronary disease requiring intervention with angioplasty
  • Willing to be randomised
  • Likely to be compliant

排除标准

  • Any clinically significant co-morbidity
  • Clinical instability within prior 6 months CABG<10 years ago unless intervention has been required
  • Unwilling to enrole or uncertainty re compliance
  • Already on long-term colchicine for unrelated condition
  • Known sensitivity to colchicine

研究者

发起方
Mark Nidorf

相似试验